Latisse

latisse-logo

LATISSE™ (bimatoprost ophthalmic solution) 0.03% is the first drug approved by the Food and Drug Administration (FDA) to promote eyelash growth.

Please contact us for a free consultation to learn if LATISSE ™ may be right for you!

Allergan, the maker of LATISSE™, states that based on clinical trials: LATISSE™ users can expect to experience longer, fuller, and darker eyelashes in as little as eight weeks, with full results in 16 weeks.

latisse atlanta

Lumigan™, a drug used to treat glaucoma, contains the same active agent as LATISSE™ and has long been known to promote longer, thicker, darker lashes. This fortunate side effect led Allergan to seek FDA approval for the cosmetic use of bimatoprost ophthalmic solution 0.03%. The story of the development of LATISSE™ is quite similar to the drug Rogaine™ — the active ingredient in Rogaine™, minoxildil, was being used in the treatment of hypertension when the unexpected side effect of regrowing scalp hair was discovered.

LATISSE™ is used differently than Lumigan™ as Lumigan™ is an eyedrop whereas LATISSE ™ is dabbed along the lash line directly.

How much does Latisse cost in Atlanta?

The price of Latisse usually ranges from $99 to $129 per box around the Atlanta area. Allergan frequently offers rebates and great promotions for Latisse. Be sure to check our specials page for current Latisse promotions. You can also sign up for Brilliant Distinctions, Allergan’s patient rewards program, to earn points and get even more deals on Latisse, BOTOX®, and JUVÉDERM®.

How does LATISSE ™ work?

This is not yet fully understood, however, research suggests that the growth of eyelashes occurs by increasing the percent of hairs in and the duration of the anagen (or growth) phase. Lashes can grow longer, thicker and darker because bimatoprost can also prolong this growth phase.

Learn More About Latisse in Atlanta

We invite you to call our Atlanta plastic surgery center at 404-367-9005 for more information or to schedule a complimentary personal consultation.